Working to produce high quality statistics in clinical trials and non-randomised studies
I’m a statistician at the primary stage of my research career, working on the design, analysis and statistical reporting of both randomised and non-randomised health research. I collaborate on many projects in the fields of oncology and respiratory diseases and am involved with teaching statistics and statistical programmes within the university.
I joined the Centre for Statistics in Medicine (CSM) in October 2015 to work primarily on the AspECT trial, a phase III randomised study of aspirin and esomeprazole chemoprevention in Barrett’s Metaplasia. I have since become involved in many other oncology studies in the areas of pancreatic cancer, prostate cancer and ovarian cancer, along with studies investigating treatments for sleep apnoea, pneumothorax and diabetic retinopathy.
I completed a BA in Mathematics and French at University College Dublin in Ireland before moving to London to study for the MSc in Medical Statistics at the London School of Hygiene and Tropical Medicine.
Barrett’s Oesophagus patients attending hospital: Baseline clinical, patient history and quality of life data from BOSS and AspECT
Reilly G. et al, (2016), National Cancer Research Institute (NCRI)
Love S. et al, (2016), GUT, 65, A130 - A131
The changing world of clinical trials 2003-2017: A view from the AspECT trial
Reilly G. et al
Contemporary extended pelvic lymph node dissection for prostate cancer in the UK – an analysis of national practice
Calleja EC. et al, European Association of Urology
Chemoprevention of Esophageal Cancer with esomeprazole and aspirin therapy: efficacy and safety in the phase III randomized factorial AspECT Trial
jankowski JJ. et al